Hims & Hers Health Options Spot-On: On May 1st, 155.95K Contracts Were Traded, With 647.07K Open Interest
Hims & Hers Health (NYSE:HIMS) Surges 24% In One Week After Novo Nordisk Partnership
CVS Caremark To Place Novo Nordisk's Wegovy On Preferred Coverage For GLP-1 Weight Loss Treatment
$HIMS Stock Is up 5% Today. Here's What We See in Our Data.
Bank of America Weighs In on Hims & Hers Health Stock Following Novo Nordisk Tie-Up
Hims & Hers Health(HIMS.US) 10% Shareholder Sells US$3.08 Million in Common Stock
Hims & Hers Health Options Spot-On: On April 30th, 149.76K Contracts Were Traded, With 617.73K Open Interest
Piper Sandler Maintains Hims & Hers Health(HIMS.US) With Hold Rating, Raises Target Price to $35
BofA Securities Maintains Hims & Hers Health(HIMS.US) With Sell Rating, Raises Target Price to $26
Daily short sale tracking: Amcor's short volume increased by 49 million, with a short sale ratio of 39%
Social Buzz: Wallstreetbets Stocks Mostly Lower Premarket Wednesday; Super Micro Computer, Snap to Decline
Why New Wegovy Deals Won't Restore Novo's Obesity Lead -- Heard on the Street -- WSJ
Sell Rating Maintained for Hims & Hers Health Amid Market Concerns Despite Strategic Partnership With Novo Nordisk
Earnings Preview: HIMS to Report Financial Results Post-market on May 05
Top Gap Ups and Downs on Tuesday: HON, SPOT, BBVA and More
U.S. stocks closed: the S&P 500 Index has risen for six consecutive days as investors anticipate Trump to adjust the tariff policy.
① Amazon was forced to terminate the plan to display the impact of tariffs on commodity pages; ② China Concept Stocks fluctuated, and the Nasdaq China Golden Dragon Index fell by 0.3%; ③ Meta released an independent AI application aiming to create a personalized Asia Vets assistant; ④ Starbucks reported a Q2 revenue of 8.8 billion dollars, below market expectations.
Hims & Hers Health Options Spot-On: On April 29th, 448K Contracts Were Traded, With 555.97K Open Interest
U.S. Small Caps Close Up; Hims & Hers Health Leads Increases
US Equities Markets End Higher Tuesday Despite Soft Economic Data
Why Hims & Hers Health and LifeMD Are Skyrocketing Today